We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

MPC:NYSEMarathon Petroleum Corporation Analysis

Data as of 2026-07-17 - not real-time

$312.10

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Marathon Petroleum (MPC) is trading at $312.1, essentially at its 52‑week high and well above its 20‑day ($271.97) and 200‑day ($215.63) moving averages, indicating a strong bullish price trend. Technical momentum is reinforced by a bullish MACD crossover and a high RSI of 77, suggesting the stock is currently overbought. Volume is trending lower, and the price sits just below the identified resistance of $312.60, raising the risk of a short‑term pullback.
Fundamentally, the company posts solid cash generation (operating cash flow > $9 bn) and a modest dividend yield of 1.28% with a low payout ratio (~25%), supporting dividend sustainability. However, the DCF‑derived fair value of roughly $118 and a negative upside/downside metric of –6.9% signal that the market is pricing in a substantial premium. Leverage is high (debt‑to‑equity > 140%) while the forward PE of 12.3 is well below the industry average of 21.4, hinting at earnings growth expectations. Recent analyst commentary downgrades the rating to “Hold” due to elevated valuation and potential margin compression, underscoring the need for caution despite a “Buy” consensus.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • RSI indicates overbought conditions
  • Price is at resistance near 52‑week high
  • Recent downgrade to Hold citing valuation risk

Medium Term

1–3 years
Neutral
Model confidence: 7/10

Key Factors

  • Forward earnings growth (trailing EPS $15.2 → forward EPS $25.27)
  • Sustainable dividend with low payout ratio
  • High leverage but strong operating cash flow

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Expansion of renewable diesel segment
  • Long‑term cash generation capacity
  • Attractive forward PE relative to industry peers

Key Metrics & Analysis

Financial Health

Revenue Growth8.80%
Profit Margin3.41%
P/E Ratio20.5
ROE27.46%
ROA5.15%
Debt/Equity146.52
P/B Ratio5.5
Op. Cash Flow$9.4B
Free Cash Flow$3.5B
Industry P/E21.4

Technical Analysis

TrendBullish
RSI77.5
Support$238.28
Resistance$312.60
MA 20$271.97
MA 50$261.70
MA 200$215.63
MACDBullish
VolumeDecreasing
Fear & Greed Index88.27

Valuation

Fair Value$118.15
Target Price$290.65
Upside/Downside-6.87%
GradeOvervalued
TypeBlend
Dividend Yield1.28%

Risk Assessment

Beta-0.06
Volatility35.03%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.